Magnesium sulfate heptahydrate ≥99%, crystals USP endotoxin tested, J.T.Baker®
Supplier: AVANTOR PERFORMANCE MATERIAL LLC
Synonyms:
sulfuric acid magnesium salt heptahydrate
, Bitter salt
, sulphuric acid magnesium salt heptahydrate
, Epsom salt
Management of Change (MOC) category = R
BAKR2505-07
BAKR2505-07
JT2505-7EA
1769.03
USD
CAJT2505-7
JT2505-7
Magnesium sulfate heptahydrate ≥99%, crystals USP endotoxin tested, J.T.Baker®
Magnesium sulphate heptahydrate
Crystals. Pyrogen tested. For preparing parenteral and nonparenteral dosage forms.
Formula:
MgSO₄·7H₂O MW: 246.48 g/mol Melting Pt: 1124 °C Density: 2.66 g/cm³ (20 °C) Storage Temperature: Ambient |
MDL Number:
MFCD00149785 CAS Number: 10034-99-8 EINECS: 231-298-2 Merck Index: 13,05715 |
Specification Test Results
GMP Manufactured Product | |
Meets U.S.P Requirements | |
CAUTION: For Manufacturing, processing or repackaging | |
Bulk Pharmaceutical Chemical | |
USP - Identification | Passes Test |
USP - pH (1 in 20) | 5.0 - 9.2 |
USP - Loss on Ignition | 40.0 - 52.0 % |
USP - Chloride (Cl) | ≤ 0.014 % |
USP - Iron (Fe) | ≤ 0.5 ppm |
USP - Selenium (Se) | ≤ 0.003 % |
USP - Assay (MgSO₄) (anhydrous basis) | 99.0 - 100.5 % |
USP - Endotoxin Concentration (2.5 EU/g max.) | Passes Test |
No Class 1,2,3 or other solvents are used or produced in the | |
manufacturing or purification of the product. | |
This product is intended for use in preparing parenteral and | |
nonparenteral dosage forms. | |
Elemental Impurities (USP 232, EP 5.20) - Information on | |
elemental impurities for this product is available on the | |
associated Product Regulatory Data Sheet and elemental impurity | |
profile report. |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...